Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.
about
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remissionRisk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG.Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan.Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.
P2860
Q27853366-C8422398-CF0E-4E70-A7B8-03DDA6B88D0CQ33865329-4CE6CC27-D150-470A-8584-DFB91C3C83D3Q36609579-FFD4B2A1-26B3-47B0-A960-AD53AE31DA01Q37695157-AB02277F-F103-4202-BACA-75519C175E22Q39396416-714C083A-517D-49A7-BD6B-28FE65B9E7DBQ40044204-CDF228F3-B121-4477-AA95-BC51A481D3DBQ40179856-256E6891-01F3-4F5D-A3AF-9F4AC000C30CQ40781300-5620F5CE-CE40-470D-BFBB-19CF0482790AQ49652236-32A799D2-410B-40EE-8698-242CEB242D3A
P2860
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@ast
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@en
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@nl
type
label
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@ast
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@en
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@nl
prefLabel
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@ast
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@en
Markedly improved outcomes and ...... an Adult Leukemia Study Group.
@nl
P2093
P2860
P50
P356
P1433
P1476
Markedly improved outcomes and ...... pan Adult Leukemia Study Group
@en
P2093
F Hayakawa
J Miyatake
Japan Adult Leukemia Study Group (JALSG)
K Fujimaki
P2860
P2888
P356
10.1038/BCJ.2014.72
P577
2014-10-17T00:00:00Z
P5875
P6179
1019814369